Recombinant immunotoxin and use in treating tumors

Details for Australian Patent Application No. 2003298794 (hide)

Event Publications

6 May 2004 Complete Application Filed

Priority application(s): 60/430,305 02.12.02 US

29 July 2004 Application Open to Public Inspection

Published as AU-A-2003298794

18 August 2005 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 23 Jun 2005

25 August 2005 Corrigenda

Applications OPI - Name Index Under the name THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, Application No. 2003298794, under INID (71) correct the name to read Memorial Sloan-Kettering Cancer Center; The Government of the United States of America, as represented by The Secretary, Department of Health and Human Services.

24 June 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.